Department of Pharmaceutical Sciences and Center for Blood Brain Barrier Research, School of Pharmacy, TTUHSC, Amarillo, TX, USA.
J Neuroendocrinol. 2021 Feb;33(2):e12931. doi: 10.1111/jne.12931. Epub 2021 Jan 28.
Increased brain microvascular permeability and disruption of blood-brain barrier (BBB) function are among hallmarks of several acute neurodegenerative disorders, including stroke. Numerous studies suggest the involvement of bradykinin (BK), neurotensin (NT) and substance P (SP) in BBB impairment and oedema formation after stroke; however, there is paucity of data in regard to the direct effects of these peptides on the brain microvascular endothelial cells (BMECs) and BBB. The present study aimed to evaluate the direct effects of BK, NT and SP on the permeability of BBB in an in vitro model based on human induced pluripotent stem cell (iPSC)-derived BMECs. Our data indicate that all three peptides increase BBB permeability in a concentration-dependent manner in an in vitro model formed from two different iPSC lines (CTR90F and CTR65M) and widely used hCMEC/D3 human BMECs. The combination of BK, NT and SP at a sub-effective concentration also resulted in increased BBB permeability in the iPSC-derived model indicating potentiation of their action. Furthermore, we observed abrogation of BK, NT and SP effects with pretreatment of pharmacological blockers targeting their specific receptors. Additional mechanistic studies indicate that the short-term effects of these peptides are not mediated through alteration of tight-junction proteins claudin-5 and occludin, but likely involve redistribution of F-actin and secretion of vascular endothelial growth factor. This is the first experimental study to document the increased permeability of the BBB in response to direct action of NT in an in vitro model. In addition, our study confirms the expected but not well-documented, direct effect of SP on BBB permeability and adds to the well-recognised actions of BK on BBB. Lastly, we demonstrate that peptidase neurolysin can neutralise the effects of these peptides on BBB, suggesting potential therapeutic implications.
脑微血管通透性增加和血脑屏障 (BBB) 功能障碍是几种急性神经退行性疾病的特征之一,包括中风。许多研究表明缓激肽 (BK)、神经降压素 (NT) 和 P 物质 (SP) 参与中风后 BBB 损伤和水肿形成;然而,关于这些肽对脑微血管内皮细胞 (BMEC) 和 BBB 的直接作用的数据很少。本研究旨在评估 BK、NT 和 SP 在基于人诱导多能干细胞 (iPSC) 衍生的 BMEC 的体外模型中对 BBB 通透性的直接影响。我们的数据表明,所有三种肽都以浓度依赖性方式增加两种不同 iPSC 系 (CTR90F 和 CTR65M) 和广泛使用的 hCMEC/D3 人 BMEC 组成的体外模型中的 BBB 通透性。在 iPSC 衍生模型中,亚有效浓度的 BK、NT 和 SP 组合也导致 BBB 通透性增加,表明它们的作用增强。此外,我们观察到用针对其特定受体的药理学阻滞剂预处理可阻断 BK、NT 和 SP 的作用。进一步的机制研究表明,这些肽的短期作用不是通过改变紧密连接蛋白 Claudin-5 和 Occludin 来介导的,而是可能涉及 F-肌动蛋白的重新分布和血管内皮生长因子的分泌。这是第一项在体外模型中记录 NT 直接作用导致 BBB 通透性增加的实验研究。此外,我们的研究证实了预期但记录不佳的 SP 对 BBB 通透性的直接作用,并补充了众所周知的 BK 对 BBB 的作用。最后,我们证明肽酶神经溶解酶可以中和这些肽对 BBB 的作用,这表明可能具有治疗意义。